Arax Advisory Partners’s GeneDx Holdings WGS Stock Holding History

Arax Advisory Partners’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.6K	Buy	+155	New	+$8.81K	﹤0.01%	4300
2026 Q1	–	Sell	-54	Closed	-$7.02K	–	4373
2025 Q4	$7.02K	Buy	54 +8	+17%	+$1.1K	﹤0.01%	2665
2025 Q3	$4.96K	Buy	+46	New	+$5.01K	﹤0.01%	2874

Other funds holding WGS

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Arax Advisory Partners's WGS Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in GeneDx Holdings (WGS) in Q2 2026: 155 shares worth $10.6K. The stake represents ﹤0.01% of the portfolio and ranks #4300 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in WGS as recently as Q4 2025.

Arax Advisory Partners first reported a position in WGS in Q3 2025 and has held it in 3 quarters since. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

Arax Advisory Partners held 155 shares of GeneDx Holdings worth $10.6K as of Q2 2026.
GeneDx Holdings was a new Arax Advisory Partners position in Q2 2026.
GeneDx Holdings made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #4300 holding.
Arax Advisory Partners first reported a position in GeneDx Holdings in Q3 2025 and has held it in 3 quarters since.
223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.